A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
Active, not recruiting · NCT04213261 · Registry updated 2026-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa | Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, epidermolysis bullosa, epidermolysis bullosa dystrophica, hereditary disease, hereditary skin disorder, recessive dystrophic epidermolysis bullosa, skin disorder, vesiculobullous skin disease | Active, not recruiting | Phase 3 | 2026-03-18 | NCT04213261 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Castle Creek Biosciences, LLC. | 2 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital Colorado | Aurora | United States | 312 |
| Dell Children'S Medical Group | Austin | United States | 4 |
| Mayo Clinic | Rochester | United States | 664 |
| Solutions Through Advanced Research, Inc. | Jacksonville | United States | 2 |
| Stanford University | Stanford | United States | 213 |